Actively Recruiting

Phase Not Applicable
Age: 40Years +
All Genders
ID04407338

Study of the Efficacy and Tolerance of the B-Dyn Medical Device Compared to Conventional Bolted Fusion in Degenerative Lumbar Stenosis Treatment Evaluating Postoperative Functional Disability, Mobility Preservation, and Adjacent Syndrome Prevention

Led by Quanta Medical · Updated on 2025-03-19

216

Participants Needed

2

Research Sites

204 weeks

Total Duration

On this page

Sponsors

Q

Quanta Medical

Lead Sponsor

C

Cousin Biotech

Collaborating Sponsor

AI-Summary

What this Trial Is About

Degenerative Lumbar Spinal Stenosis (LSS) is a common condition affecting over 102 million people annually. It involves narrowing of the spinal canal in the lower back, causing pain and leg problems. When symptoms worsen despite medical treatment, surgery is recommended. This study compares the B-Dyn dynamic stabilization device with conventional rigid fusion surgery to see if B-Dyn can maintain function and mobility better after surgery and reduce degeneration of adjacent spine segments. Participants will receive either the B-Dyn device or conventional bolted fusion with or without a cage during surgery under general anesthesia. The B-Dyn device stabilizes the operated area while preserving some mobility, using screws and a movable rod. Conventional fusion connects screws rigidly to stabilize the spine segment. The study lasts 60 months with a 56-month inclusion period to enroll about 216 patients. During the study, participants will have regular assessments including disability questionnaires (Oswestry Disability Index), pain scales, quality of life surveys, anxiety evaluations, X-rays, MRI scans, and walking tests at multiple timepoints up to 60 months after surgery. Researchers will monitor safety, device tolerance, mobility preservation, and complications such as adjacent segment degeneration. The primary outcome is the degree of functional disability related to low back pain at 12 months post-surgery.

CONDITIONS

Brief Title

Efficacy and Tolerance Study of B-DYN Versus Conventional Fusion in the Treatment of Lumbar Stenosis on the Degree of Post-operative Functional Incapacity (BDYNCLIN)

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Stenosis on 1, 2, or 3 disc levels as shown by lumbar spine MRI
  • Grade 1 or no spondylolisthesis at the treated spinal level
  • Neurological symptoms or neurogenic claudication with pain score above 30
  • Symptoms lasting more than 3 months despite medical treatment
  • No contraindication to fusion or B-Dyn device application
  • Age 40 years or older
  • Able to provide informed written consent
  • Able to respond to questionnaires and communicate in the study country language
  • Affiliated with or entitled to a social security scheme
Not Eligible

You will not qualify if you...

  • Spondylolisthesis greater than grade 1 at the treated spinal level
  • Surgery required on more than 3 disc levels
  • Degenerative scoliosis with Cobb angle greater than 20 degrees
  • Stenosis only at L5-S1 level
  • Previous instrumented lumbar surgery at the upper or lower level, except intra-spinous device at lower level
  • Stenosis not caused by degenerative changes
  • Isolated disc herniation
  • Other vertebral damage such as ankylosing spondylitis, cancer, or neurological disorders
  • History of vertebral compression fractures at the treated level
  • History of osteoporotic fractures
  • Psychological disorders or drug addiction impairing study participation
  • Chronic infection
  • Withdrawal of consent
  • Pregnancy or breastfeeding
  • Participation in another clinical trial within 3 months prior
  • Predicted unavailability or legal constraints
  • Allergy to any components of the medical device

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Day of surgery plus immediate recovery period

Participants undergo surgery with either the B-Dyn device or conventional bolted fusion under general anesthesia to treat lumbar stenosis.

1 surgical visit and immediate post-operative hospital stay

Post-operative Follow-up

Duration - Up to 60 months post-surgery

Participants are followed up to assess functional disability, mobility preservation, pain, and safety after surgery.

Visits at 2 months, 12 months, 24 months, and 60 months post-surgery

Trial Site Locations

Total: 2 locations

1

CHU [University Hospital Center]of Bordeaux - Le Tripode - GH Pellegrin/ Department of Orthopaedic and Trauma Surgery Spinal Surgery Unit

Bordeaux, France, 33000

Actively Recruiting

2

Clinique Des Cedres

Cornebarrieu, France, 31700

Not Yet Recruiting

Loading map...

Research Team

V

Vincent POINTILLART, Professor

B

Bertrand DEBONO, Doctor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Effect of Pre-existing Adjacent Segment Degeneration on Long...

Degenerative Lumbar Spinal Stenosis

Actively Recruiting

1 location

Mid- or High-flex Rods Versus Low-flex Rods of SpineShape Sy...

Degenerative Lumbar Spinal Stenosis

Actively Recruiting

2 locations

Preventive Effect of Limited Decompression on Adjacent Segme...

Degenerative Lumbar Spinal Stenosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Kinematic evaluation of the adjacent segments after lumbar instrumented surgery: a comparison between rigid fusion and dynamic non-fusion stabilization.

Yuichiro Morishita, Hideki Ohta, Masatoshi Naito...

https://pubmed.ncbi.nlm.nih.gov/21301893